Inventor · disambiguated record
Douglas J. Gordon
Also filed as: GORDON DOUGLAS · GORDON DOUGLAS J
7 granted patents·2 pending applications·62 citations·filing 1991–2012
82Inventor score
Files withBIOFRONTERA BIOSCIENCE GMBH2GORDON DOUGLAS J2HOECHST CELANESE CORP2CLARIANT FINANCE BVI LTD1SUPERIOR EQUINE PHARMACEUTICAL1
Top patents by PatentIndex Score
9 records- 0188US7060711B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2002·Granted Jun 13, 2006·24 cites·10 claims
- 0275US5342727ACopolymers of 4-hydroxystyrene and alkyl substituted-4-hydroxystyrene in admixture with a photosensitizer to form a photosensitive compositionHOECHST CELANESE CORP·Filed 1991·Granted Aug 30, 1994·25 cites·18 claims
- 0362US2011021591A1Phenylbutazone carrier formulation showing increased bioactivity in animalsGORDON DOUGLAS J·Filed 2009·Application pending·0 cites
- 0456US7511064B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2006·Granted Mar 31, 2009·0 cites·21 claims
- 0547US5807947ACopolymers 4-hydroxystyrene and alkyl substituted-4-hydroxystyreneCLARIANT FINANCE BVI LTD·Filed 1994·Granted Sep 15, 1998·8 cites·8 claims
- 0645US8524759B2Phenylbutazone carrier formulation showing increased bioactivity in animalsGORDON DOUGLAS J·Filed 2012·Granted Sep 3, 2013·0 cites·20 claims
- 0737US5739295APhotoactive coumarin sulfonate compoundsHOECHST CELANESE CORP·Filed 1997·Granted Apr 14, 1998·1 cites·30 claims
- 0837US2003022920A11-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonistFiled 2002·Application pending·0 cites
- 0930US6022563APhenylbutazone carrier formulationSUPERIOR EQUINE PHARMACEUTICAL·Filed 1999·Granted Feb 8, 2000·4 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Douglas J. Gordon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →